Literature DB >> 3904231

Eight-year follow-up of adjuvant therapy for stage II breast cancer.

C A Hubay, N H Gordon, O H Pearson, J S Marshall, W L McGuire.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3904231     DOI： 10.1007/bf01655189

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  18 in total

Review 1.  The qualification and disqualification of patients and events in long-term cardiovascular clinical trials.

Authors:  M Gent; D L Sackett
Journal:  Thromb Haemost       Date:  1979-02-28       Impact factor: 5.249

2.  Covariance analysis of censored survival data.

Authors:  N Breslow
Journal:  Biometrics       Date:  1974-03       Impact factor: 2.571

3.  Progesterone receptors as a prognostic factor in stage II breast cancer.

Authors: 
Journal:  N Engl J Med       Date:  1984-05-17       Impact factor: 91.245

4.  Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer.

Authors:  A U Buzdar; J U Gutterman; G R Blumenschein; G N Hortobagyi; C K Tashima; T L Smith; E M Hersh; E J Freireich; E A Gehan
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860

5.  Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: five-year results.

Authors:  O H Pearson; C A Hubay; J S Marshall; N H Gordon; W L McGuire; E G Mansour; R E Hermann; J C Jones; W J Flynn; C Eckert
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

6.  Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-up.

Authors:  C A Hubay; N H Gordon; J P Crowe; S P Guyton; O H Pearson; J S Marshall; E G Mansour; R E Hermann; J C Jones; W J Flynn
Journal:  Surgery       Date:  1984-07       Impact factor: 3.982

7.  Adjuvant therapy of stage II breast cancer: 48-month follow-up of a prospective randomized clinical trial.

Authors:  C A Hubay; O H Pearson; J S Marshall; T A Stellato; R S Rhodes; S M DeBanne; J Rosenblatt; E G Mansour; R E Hermann; J C Jones; W J Flynn; C Eckert; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

Review 8.  Hormone receptors. An update and application.

Authors:  C A Hubay; B Arafah; N H Gordon; S P Guyton; J P Crowe
Journal:  Surg Clin North Am       Date:  1984-12       Impact factor: 2.741

9.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640
View more
  2 in total

1.  The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect.

Authors:  L E Rutqvist; B Cedermark; U Glas; H Johansson; B Nordenskjöld; L Skoog; A Somell; T Theve; S Friberg; J Askergren
Journal:  Breast Cancer Res Treat       Date:  1987-12       Impact factor: 4.872

Review 2.  The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.

Authors:  R Vihko; A Alanko; V Isomaa; A Kauppila
Journal:  Med Oncol Tumor Pharmacother       Date:  1986
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.